GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $23,921,000 | +127.5% | 549,524 | +127.7% | 0.00% | +200.0% |
| Q1 2022 | $10,514,000 | +1.9% | 241,367 | +3.2% | 0.00% | 0.0% |
| Q4 2021 | $10,316,000 | +5.8% | 233,949 | -8.3% | 0.00% | 0.0% |
| Q3 2021 | $9,753,000 | -5.5% | 255,230 | -1.5% | 0.00% | 0.0% |
| Q2 2021 | $10,317,000 | +28.8% | 259,078 | +15.5% | 0.00% | 0.0% |
| Q1 2021 | $8,008,000 | +11.7% | 224,406 | +15.2% | 0.00% | 0.0% |
| Q4 2020 | $7,172,000 | -31.8% | 194,866 | -30.7% | 0.00% | -50.0% |
| Q3 2020 | $10,520,000 | -7.6% | 281,088 | +0.7% | 0.00% | 0.0% |
| Q2 2020 | $11,387,000 | -33.6% | 279,172 | -38.3% | 0.00% | -50.0% |
| Q1 2020 | $17,153,000 | -74.6% | 452,660 | -68.5% | 0.00% | -69.2% |
| Q4 2019 | $67,437,000 | -21.9% | 1,435,121 | -29.1% | 0.01% | -23.5% |
| Q3 2019 | $86,395,000 | +113.9% | 2,024,288 | +100.3% | 0.02% | +112.5% |
| Q2 2019 | $40,392,000 | +42.2% | 1,010,809 | +48.7% | 0.01% | +33.3% |
| Q1 2019 | $28,412,000 | +17.7% | 679,914 | +7.6% | 0.01% | 0.0% |
| Q4 2018 | $24,147,000 | +131.1% | 631,921 | +143.0% | 0.01% | +200.0% |
| Q3 2018 | $10,448,000 | -7.3% | 260,081 | -7.0% | 0.00% | 0.0% |
| Q2 2018 | $11,276,000 | +97.3% | 279,710 | +91.2% | 0.00% | +100.0% |
| Q1 2018 | $5,715,000 | +66.1% | 146,272 | +50.9% | 0.00% | 0.0% |
| Q4 2017 | $3,440,000 | -44.3% | 96,952 | -36.7% | 0.00% | 0.0% |
| Q3 2017 | $6,180,000 | -33.8% | 153,055 | -29.3% | 0.00% | -50.0% |
| Q2 2017 | $9,334,000 | -1.5% | 216,452 | -3.7% | 0.00% | 0.0% |
| Q1 2017 | $9,480,000 | -76.8% | 224,844 | -78.8% | 0.00% | -80.0% |
| Q4 2016 | $40,812,000 | -70.7% | 1,059,778 | -67.2% | 0.01% | -70.6% |
| Q3 2016 | $139,210,000 | -52.5% | 3,227,717 | -52.3% | 0.03% | -53.4% |
| Q2 2016 | $293,154,000 | -30.8% | 6,764,066 | -35.3% | 0.07% | -32.4% |
| Q1 2016 | $423,859,000 | -16.1% | 10,452,726 | -16.5% | 0.11% | -15.0% |
| Q4 2015 | $505,098,000 | -5.7% | 12,517,927 | -10.2% | 0.13% | -11.2% |
| Q3 2015 | $535,775,000 | +39.3% | 13,934,344 | +50.8% | 0.14% | +57.1% |
| Q2 2015 | $384,747,000 | +323.7% | 9,237,629 | +369.5% | 0.09% | +333.3% |
| Q1 2015 | $90,804,000 | -10.6% | 1,967,607 | -17.2% | 0.02% | -8.7% |
| Q4 2014 | $101,596,000 | +16.5% | 2,377,056 | +25.3% | 0.02% | +9.5% |
| Q3 2014 | $87,199,000 | -15.5% | 1,896,849 | -1.7% | 0.02% | -19.2% |
| Q2 2014 | $103,147,000 | -0.0% | 1,928,692 | -0.1% | 0.03% | -7.1% |
| Q1 2014 | $103,156,000 | +25.0% | 1,930,665 | +24.9% | 0.03% | +21.7% |
| Q4 2013 | $82,499,000 | +24.4% | 1,545,228 | +16.9% | 0.02% | +15.0% |
| Q3 2013 | $66,334,000 | -5.0% | 1,322,178 | -5.4% | 0.02% | -9.1% |
| Q2 2013 | $69,844,000 | – | 1,397,702 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |